This inventor holds 6 USPTO granted patents and 1 EPO patent. Top assignees: University of California, Sugen Incorporated, Exelixis, Inc.. Active years: 1998-2019.
Company Filing History:
3 out of 16,008 
2 out of 157 
1 out of 177 
Years Active: 1998-2019
Title: The Innovations of Douglas O. Clary
Introduction
Douglas O. Clary is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of medical treatments, particularly in the areas of osteoporosis and neurotrophin mimetics. With a total of 6 patents to his name, Clary's work reflects a commitment to advancing healthcare solutions.
Latest Patents
Among his latest patents is a method for treating osteoporosis. This invention utilizes N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide to provide an innovative approach to managing this condition. Additionally, he has developed antibodies that mimic the actions of neurotrophins. This patent focuses on the use and production of immunoglobulins that activate trk receptors, imitating the effects of neurotrophins, while also providing immunoglobulins that block trk receptor activation.
Career Highlights
Clary has worked with prestigious organizations such as the University of California and Sugen Incorporated. His experience in these institutions has allowed him to collaborate on groundbreaking research and development projects.
Collaborations
Some of his notable coworkers include Gisela Weskamp and LeeAnn R. Austin. Their collaborative efforts have contributed to the success of various projects and innovations in the field.
Conclusion
Douglas O. Clary's contributions to medical innovation, particularly in osteoporosis treatment and neurotrophin mimetics, highlight his role as a significant inventor in the healthcare sector. His work continues to influence advancements in medical science and patient care.